• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依达赛珠单抗在逆转抗凝作用中的作用是什么?

What is the role of andexanet alfa in the reversal of anticoagulant effects?

机构信息

Jenna Hill Sewell is a pharmacy resident at the Gulf Coast Veterans Healthcare System in Biloxi, Miss. LaKeisha Williams is a clinical associate professor at Xavier University of Louisiana College of Pharmacy in New Orleans, La. Ellen McKnight is a community pharmacist at Walgreens Pharmacy in Memphis, Tenn. Anthony Nguyen is a clinical pharmacist at Ochsner Medical Center in New Orleans. Miroslav Sarac is an assistant professor at the Faculty of Pharmacy, Novi Sad, University Business Academy in Novi Sad, Serbia. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2021 Jan 1;34(1):8-9. doi: 10.1097/01.JAA.0000723956.47623.90.

DOI:10.1097/01.JAA.0000723956.47623.90
PMID:33332828
Abstract

Although using direct oral anticoagulants increases patient risk for hemorrhagic events, FDA-approved options for reversing anticoagulant effects are limited. This article discusses one of the more recent FDA-approved antidotes, andexanet alfa, and provides guidelines for its safe and effective use.

摘要

虽然直接口服抗凝剂会增加患者出血事件的风险,但获得 FDA 批准的逆转抗凝效果的方法有限。本文讨论了最近获得 FDA 批准的一种解毒剂——andexanet alfa,并提供了其安全有效使用的指南。

相似文献

1
What is the role of andexanet alfa in the reversal of anticoagulant effects?依达赛珠单抗在逆转抗凝作用中的作用是什么?
JAAPA. 2021 Jan 1;34(1):8-9. doi: 10.1097/01.JAA.0000723956.47623.90.
2
Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.安多凝血素α:一种用于逆转抗凝治疗的重组人凝血因子Xa模拟物。
Drugs Today (Barc). 2017 May;53(5):271-282. doi: 10.1358/dot.2017.53.5.2630780.
3
Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence.用于逆转Xa因子抑制剂的andexanet alfa:证据的批判性综述。
Future Cardiol. 2019 Nov;15(6):395-404. doi: 10.2217/fca-2019-0038. Epub 2019 Oct 31.
4
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.直接口服抗凝剂的特异性解毒剂:临床试验数据的全面综述
Int J Cardiol. 2016 Jul 1;214:292-8. doi: 10.1016/j.ijcard.2016.03.056. Epub 2016 Mar 28.
5
Is It Truly "Alpha"? Incidence of Thrombotic Events With Andexanet Alfa at a Single Academic Medical Center.它真的是“阿哌沙班”吗?单家学术医疗中心使用安多昔单抗时血栓形成事件的发生率。
Ann Emerg Med. 2020 May;75(5):675-676. doi: 10.1016/j.annemergmed.2019.12.026.
6
Andexanet Alfa: First Global Approval.依达赛珠单抗:全球首次获批。
Drugs. 2018 Jul;78(10):1049-1055. doi: 10.1007/s40265-018-0940-4.
7
Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.依达赛珠单抗,非肝素类药物逆转普通肝素抗凝作用的可能选择。
Ann Pharmacother. 2021 Feb;55(2):261-264. doi: 10.1177/1060028020943160. Epub 2020 Jul 15.
8
Andexanet Alfa for Reversing Factor Xa Inhibition.用于逆转Xa因子抑制作用的andexanet alfa。
Cardiol Rev. 2019 Mar/Apr;27(2):108-111. doi: 10.1097/CRD.0000000000000230.
9
Throwing it in reverse: An update on reversal of oral factor Xa inhibitors.逆向而行:口服Xa因子抑制剂逆转的最新进展
Am J Emerg Med. 2019 Oct;37(10):1978-1980. doi: 10.1016/j.ajem.2019.04.007. Epub 2019 Apr 8.
10
[Andexanet alfa (ONDEXXYA for Intravenous Injection 200 mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence].[andexanet alfa(注射用安多昔单抗200毫克),一种直接Xa因子抑制剂的逆转剂:药理学特性和临床证据]
Nihon Yakurigaku Zasshi. 2023;158(1):89-100. doi: 10.1254/fpj.22107.

引用本文的文献

1
Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National Survey.美国验证创伤中心使用andexanet alfa 逆转因子 Xa 抑制剂:一项全国性调查。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241238013. doi: 10.1177/10760296241238013.
2
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period.美国胃肠病学会 - 加拿大胃肠病学会临床实践指南:急性胃肠道出血及内镜检查期间抗凝剂和抗血小板药物的管理
J Can Assoc Gastroenterol. 2022 Mar 17;5(2):100-101. doi: 10.1093/jcag/gwac010. eCollection 2022 Apr.